- Home
- ORC vs IMNM Comparison
ORC vs IMNM Comparison
Compare ORC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- IMNM
- Stock Information
- Founded
- ORC 2010
- IMNM 2006
- Country
- ORC United States
- IMNM United States
- Employees
- ORC N/A
- IMNM N/A
- Industry
- ORC Real Estate Investment Trusts
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- ORC Real Estate
- IMNM Health Care
- Exchange
- ORC Nasdaq
- IMNM Nasdaq
- Market Cap
- ORC 660.1M
- IMNM 542.6M
- IPO Year
- ORC 2013
- IMNM 2020
- Fundamental
- Price
- ORC $6.55
- IMNM $7.91
- Analyst Decision
- ORC Buy
- IMNM Strong Buy
- Analyst Count
- ORC 3
- IMNM 6
- Target Price
- ORC $9.50
- IMNM $26.00
- AVG Volume (30 Days)
- ORC 4.9M
- IMNM 1.7M
- Earning Date
- ORC 04-24-2025
- IMNM 05-13-2025
- Dividend Yield
- ORC 22.02%
- IMNM N/A
- EPS Growth
- ORC N/A
- IMNM N/A
- EPS
- ORC 0.58
- IMNM N/A
- Revenue
- ORC $54,406,000.00
- IMNM $9,041,000.00
- Revenue This Year
- ORC N/A
- IMNM N/A
- Revenue Next Year
- ORC $51.24
- IMNM $1,259.12
- P/E Ratio
- ORC $11.38
- IMNM N/A
- Revenue Growth
- ORC N/A
- IMNM N/A
- 52 Week Low
- ORC $5.69
- IMNM $5.15
- 52 Week High
- ORC $9.01
- IMNM $19.07
- Technical
- Relative Strength Index (RSI)
- ORC 35.29
- IMNM 55.28
- Support Level
- ORC $5.85
- IMNM $6.96
- Resistance Level
- ORC $6.46
- IMNM $7.56
- Average True Range (ATR)
- ORC 0.34
- IMNM 0.69
- MACD
- ORC -0.02
- IMNM 0.26
- Stochastic Oscillator
- ORC 45.26
- IMNM 98.22
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.